A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients (Q42993950)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients |
scientific article published in August 2005 |
Statements
1 reference
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients (English)
1 reference
Timothy L Pruett
1 reference
Norah Terrault
1 reference
Gary L Davis
1 reference
David R Nelson
1 reference
Thomas D Schiano
1 reference
Courtney V Fletcher
1 reference
Christine V Sapan
1 reference
Laura N Riser
1 reference
Yufeng Li
1 reference
Richard J Whitley
1 reference
John W Gnann
1 reference
Collaborative Antiviral Study Group
1 reference
1 August 2005
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference